These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6428306)

  • 1. Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits.
    Fass RJ; Wright CA
    Antimicrob Agents Chemother; 1984 Apr; 25(4):408-10. PubMed ID: 6428306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.
    Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Feb; 27(2):224-6. PubMed ID: 3920960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
    Levison ME; Kobasa WD
    Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
    Hellinger WC; Rouse MS; Rabadan PM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1272-5. PubMed ID: 1416826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate.
    Adelman RD; Wirth F; Rubio T
    J Pediatr; 1987 Dec; 111(6 Pt 1):888-93. PubMed ID: 3316564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin-netilmicin synergism against Streptococcus faecalis.
    Korzeniowski OM; Wennersten C; Moellering RC; Sande MA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):430-4. PubMed ID: 122522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.
    Moellering RC; Murray BE; Schoenbaum SC; Adler J; Wennersten CB
    J Infect Dis; 1980 Jan; 141(1):81-6. PubMed ID: 6767791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J; Kaye D
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental endocarditis in rabbits. 7. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and gentamicin.
    Gutschik E
    Acta Pathol Microbiol Immunol Scand B; 1982 Aug; 90(4):295-302. PubMed ID: 6814183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM; Keeley JM
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.
    Gerecht WB; Henry NK; Hoffman WW; Muller SM; LaRusso NF; Rosenblatt JE; Wilson WR
    Arch Intern Med; 1989 Jun; 149(6):1279-84. PubMed ID: 2658897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.